John Paulson

John Paulson

Last Update: 12-15-2015

Number of Stocks: 61
Number of New Stocks: 9

Total Value: $18,723 Mil
Q/Q Turnover: 15%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

John Paulson Watch

  • Valeant's Share Price Continues to Decline

    Valeant Pharmaceuticals Inc. (NYSE:VRX), one of the best specialty drugmakers, has been trading down since September 2015 when the last rally was seen. Since then, the stock plunged to less than half of its value.


      


  • Guru Stocks That Have Outperformed S&P 500

    The following are some of the stocks that outperformed the S&P 500 Index over the last 12 months and have been bought by gurus during the last quarter.


    JetBlue Airways Corp. (JBLU) has a market cap of $6.78 billion, and during the last 12 months has outperformed the S&P 500 Index by 38.1%. Six gurus are currently holding the company.

      


  • Dow-DuPont Merger Rates High on Paulson Checklist

    On Dec. 11, Dow Chemical (NYSE:DOW) and DuPont (NYSE:DD) announced both its boards had approved an all-stock merger of equals that will create a combined company called DowDuPont, which will have a market cap of $130 billion as of the announcement.

    GuruFocus provides several checklists on each stock page that allows users to analyze companies and save their checklists on the website. Along with a customized checklist feature, one of the predefined lists is John Paulson (Trades, Portfolio)’s Merger Arbitrage Checklist. Paulson’s investment firm specializes in event-driven situations, including mergers and acquisitions.  


  • Always Channel Your Inner Unfrozen Caveman Lawyer

    The Unfrozen Caveman Lawyer was a character from an SNL skit. Phil Hartman played a caveman who fell into a crevasse and was frozen, then later thawed out by scientists. He went on to law school and became the Unfrozen Caveman Lawyer. He was a suave, smooth lawyer who played up his caveman background with the catchphrase “your world frightens and confuses me” for comedic effect.


    When investing, you should always listen to your inner Unfrozen Caveman Lawyer. Your inner caveman is key to avoiding stock market disasters such as the saga surrounding Valeant Pharmaceuticals (VRX). When a company’s business model confuses (and maybe even frightens) you, it is a good idea to just stay away. There are thousands of stocks out there so there is no need to invest in something scary that you don’t understand.

      


  • John Paulson Sells Stake in Broadcom, Cuts Cablevision Holding

    John Paulson (Trades, Portfolio) is the president and portfolio manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the third-largest hedge fund in the world, managing approximately $29 billion and focusing on merger, event and distressed strategies.


    The hedge fund has a portfolio composed of 61 stocks with a total value of $18,723 million. The following are the most heavily weighted sales during the third quarter.

      


  • John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    John Paulson (Trades, Portfolio) made billions in the housing crash and employs an event-driven arbitrage investing strategy at his firm Paulson & Co., where he manages about $19.5 billion. Outsized bets tend to make the manager’s returns vary to extremes. For instance, in recent years his funds lost as much as 36% for 2014, after gaining as much as 46% in 2013.


    In the third quarter, the investor started nine stock positions, holding 61 positions in total with a value of $18.7 billion. Paulson had a large bet on healthcare overall, with 48.3% of his portfolio invested in the sector.

      


  • John Paulson Increases Holding in Teva Pharmaceutical

    John Paulson is an American hedge fund manager and billionaire who founded the New York-based investment management firm Paulson & Co. in 1994. Paulson has most recently added 18,000,000 shares of Teva Pharmaceutical Industries (NYSE:TEVA), a 746.48% increase in his holding. Paulson & Co. have also bought 2,938,500 shares of Perrigo Co. PLC (NYSE:PRGO) and 7,007,346 shares of CIT Group Inc. (NYSE:CIT).


    Teva Pharmaceutical Industries was incorporated in Israel on Feb. 13, 1944. The company manufactures generic pharmaceutical products

      


  • How the Walgreens-Rite Aid Deal Stacks Up Against Paulson's Merger Arbitrage Checklist

    Walgreens Boots Alliance (NASDAQ:WBA) announced on Oct. 27 it would acquire Rite Aid (NYSE:RAD) in a deal worth more than $17 billion, combining the largest and third-largest drugstore chains in the country in terms of number of stores.


    Walgreens will pay $9.00 per share in cash — a premium of 48% from Rite Aid’s closing price on Oct. 26 — and will acquire Rite Aid’s net debt. The deal is expected to close in the second half of 2016.

      


  • Is Carl Icahn Right About AIG?

    Investors tend to shy away from taking on shares in one-stop-shops. After all, it’s generally far safer to place your faith in a meticulously focused business that’s simple to understand and easier to manage. That’s why the banking and insurance sectors have seen a record number of spinoffs over the past couple of years – and it’s also why infamously active investor Carl Icahn (Trades, Portfolio) has called for a breakup of American International Group (NYSE:AIG).


    Last week, Icahn delivered a scathing open letter to AIG’s CEO, Peter Hancock, in which he argued that AIG is simply "too big to succeed." According to Icahn, the $82 billion insurer’s status as a Systemically Important Financial Institution (SIFI) has created an “increasingly onerous regulatory burden” that is ultimately restricting the company’s overall potential. Consequently, Icahn would see AIG split its three primary businesses into separate companies: property and casualty, mortgage and life. Peter Hancock wasn’t necessarily pleased by Icahn’s letter, but the news did lift shares by 4.4% on Wednesday.

      


  • Ackman, Paulson Funds Hit by Scathing Short-Seller Report on Valeant

    Investors like Bill Ackman (Trades, Portfolio), Ruane Cunniff (Trades, Portfolio) and John Paulson (Trades, Portfolio) took hits to their portfolio today after a company published a damning reporting on one of their key holdings, Valeant Pharmaceutical (NYSE:VRX). The company’s shares plunged as much as 33% on Wednesday, after providing the investors solid paper gains this year.


      


  • An Interview With Economist Gary Shilling

    The purpose of this interview


    We sincerely believe that a proper understanding of how the economic machine works will lead to a more optimal allocation of capital. In investing, as in other fields, working hard, intelligently and in teams towards a common dream seems to have delivered better results to those who have done so. Applying the preceding process to understanding economics can be one of many other factors to differentiate the good from the great capital allocator in the future. Enabling investors to identify countries with the best growth potential in which to invest and, just as important, with asset bubbles, will enable them to profit from their consequences rather than paying for them. This interview was conducted with this idea in mind to enable you to understand the process Gary Shilling has used to identify unbalanced economic situations. Mr. Shilling also describes what he thinks will be the economic future of certain countries, and why.

      


  • American International Group One of Most Weighted Buys in Q2 2015

    The hedge fund American International Group (NYSE:AIG) in its last quarterly 13F reported a total value of its portfolio of $25 billion, with an increase of 2.94% since the previous quarter. During Q2 2015, the firm bought 341 new stocks and increased 1,794 of its existing stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Allergan PLC (AGN) with an impact of 0.20% on its portfolio.

      


  • Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, NICE Systems

    Hedge fund Menta Capital disclosed an equity portfolio valued at $612.3 million as of the end of the second quarter of 2015. The equity portfolio is mainly invested in finance (20%), technology (19%) and consumer discretionary (14%) stocks. 


    In this article, we will look into the top three picks held at the end of Q2. Of the 10 largest holdings from Menta Capital’s equity portfolio (which comprise 5.47% of the total portfolio value), the three top are: Teva Pharmaceutical Industries Limited (NYSE:TEVA), NICE Systems Ltd. (NASDAQ:NICE) and Mellanox Technologies Ltd. (NASDAQ:MLNX).

      


  • Sheets Smith Wealth Management Buys Companies With no Debts

    Sheets Smith Wealth Management is a hedge fund based in North Carolina that, on its last quarterly 13F, reported a total value of its portfolio of $365 million, with an increase of 1.02% since the previous quarter. During Q2 2015 the investment professional bought 19 new stocks and increased 84 of its existing stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Allergan PLC (AGN) with an impact of 2.48% on its portfolio. The Investor, as well as other hedge funds such as Moody Lynn & Lieberson, Lawrence W. Kelly & Associates and M&R Capital Management, have found the company attractive, that is engaged in development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products. It also develops and out-licenses generic pharmaceutical products in Europe through its Medis third-party business. It operates in three segments, Pharma, Specialty Brands and Anda Distribution.

      


  • Moody Lynn & Lieberson Top Buys in Second Quarter

    At the end of the second quarter of 2015, hedge fund Moody Lynn & Lieberson reported a total value of its portfolio of $628 million, with no substantial changes since the previous quarter. During the quarter, it bought 35 new stocks and increased 72 of its stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Prudential Financial Inc (PRU) with an impact of 2.35% on its portfolio. The company through its subsidiaries and affiliates offers financial products and services, including life insurance, annuities, retirement-related services, mutual funds and investment management. It offers these products and services to individual and institutional customers through proprietary and third party distribution networks. The company's businesses are separated into the Financial Services Businesses and the Closed Block Business.

      


  • Taconic Capital Buys Time Warner Cable, Broadcom

    At the end of the second quarter of 2015, the hedge fund Taconic Capital Advisors reported a total value of its portfolio of $3,540 million, after it added 32 new stocks to its portfolio and increased 27 of its stakes. The following are the most heavily weighted buys during the quarter.


    It bought shares of Time Warner Cable Inc (TWC) with an impact of 6.21% on its portfolio. The company provides video, high-speed data and voice services in five geographic areas: New York State, the Carolinas, the Midwest, Southern California and Texas. The Company has three reportable segments: Residential Services, Business Services and Other Operations.

      


  • John Paulson Finds Opportunity in Recently Bankrupt Overseas Shipholding Group

    John Paulson (Trades, Portfolio), president and portfolio manager of hedge fund Paulson & Co., purchased a new holding in Overseas Shipholding Group (OSGB) on Aug. 3, buying 56,425,082 shares for an average of $3.61 per share.

    Overseas Shipholding is engaged in the ocean transportation of crude oil and petroleum products. The company owns a fleet of 89 double-hulled vessels, 65 of which are operated in international markets. The stock price rose marginally by 3% over the past year and closed at $3.61 on Aug. 13.  


  • GMT Capital Corp Starts to Invest in Leisure Industry

    At the end of the second quarter of 2015, the hedge fund GMT Capital Corp reported a total value of its portfolio of $3,826,630,000 with a decrease of 7.36% since the previous quarter.


    During the Q2 2015, the hedge fund bought 26 new stocks and increased 21 stakes. The following are the most heavily weighted buys of U.S. companies the hedge fund has done during that quarter, and two of them are from the Global Leisure Industry.

      


  • Follow Bill Ackman in Valeant Pharmaceuticals

    Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC).


    Bill Ackman (Trades, Portfolio)´s Pershing Square disclosed an equity portfolio valued at $14.97 billion at the end of the first quarter of 2015. The equity portfolio is mainly invested in Health Care (46%), Materials (31%) and Transports (19%) stocks.

      


  • Smart Guru John Paulson Bullish on Actavis

    John Paulson (Trades, Portfolio) increased his position in Actavis PLC (NYSE:ACT) through Paulson & Co by 262% to $1.68 billion in the company's latest filing, with 5.6 million shares. Actavis is the fund's second largest holding in its $19.64 billion portfolio behind Shire PLC (NASDAQ:SHPG) and Time Warner Cable Inc (NYSE:TWC), representing 10.1% and 6.6% of Paulson's portfolio, respectively.


    Actavis PLC, formerly known as Actavis Limited was incorporated in Ireland, in 2013. It is an integrated specialty pharmaceutical company engaged in development, manufacturing, marketing, sale and distribution of generic, branded generic, brand name, biosimilar and over-the-counter pharmaceutical products.

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet



Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK